Watch ESMC. Know when insiders buy.
One email the day a filing lands. Free.
ESMC
ESCALON MEDICAL CORP
0.16
−0.01 −5.88%
USD · close Sep 11
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
52
WATCH · shorts 52
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.2MP/E 1.5DIV YIELD —FCF YIELD -12.13%REV TTM —NET INCOME $1.9M +198.8%NET CASH $3.3M52W 0.12 – 0.35SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2026 · Mar 31 | — | — | — | −$419K | $2.4M | +774.3% | 0.16 | $281K | $0 | $281K | May 15 |
| Q2 2026 · Dec 31 | — | — | — | $99K | $98K | −60.3% | 0.01 | −$517K | $0 | −$517K | May 15 |
| Q1 2026 · Sep 30 | — | — | — | −$203K | −$240K | — | -0.03 | $85K | $4K | $81K | Feb 17 |
| Q4 2025 · Jun 30derived | — | — | — | −$372K | −$380K | −382.5% | -0.03 | $16K | $4K | $12K | Sep 29 |
| Q3 2025 · Mar 31 | $3.5M | +28.9% | 46.1% | $276K | $271K | — | 0.02 | $31K | $0 | $31K | May 15 |
| Q2 2025 · Dec 31 | $3.2M | +12.2% | 48.9% | $256K | $246K | — | 0.02 | $301K | $0 | $301K | May 15 |
| Q1 2025 · Sep 30 | — | — | — | −$27K | −$32K | — | -0.01 | $33K | $0 | $33K | Feb 17 |
| Q4 2024 · Jun 30derived | — | — | — | $138K | $134K | −32.2% | 0.02 | −$340K | $9K | −$349K | Sep 29 |
| Q3 2024 · Mar 31 | $2.7M | — | 41.4% | −$157K | −$162K | — | -0.02 | $175K | −$9K | $184K | May 14 |
| Q2 2024 · Dec 31 | $2.9M | — | 44.0% | −$71K | −$76K | — | -0.01 | −$322K | $22K | −$344K | May 14 |
| Q1 2024 · Sep 30 | $2.9M | — | 44.0% | −$16K | −$21K | — | 0.00 | −$116K | $18K | −$134K | May 14 |
| Q4 2023 · Jun 30derived | — | — | — | $205K | $198K | — | 0.01 | $355K | $0 | $355K | Sep 30 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Jun 30 | — | — | $133K | $106K | — | 0.00 | $381K | $4K | $377K | — | — |
| FY2024 · to Jun 30 | — | — | −$104K | −$125K | — | -0.02 | −$603K | $40K | −$643K | — | — |
| FY2023 · to Jun 30 | — | — | $479K | $457K | — | 0.03 | $325K | $7K | $318K | — | — |
| FY2022 · to Jun 30 | — | — | −$470K | $18K | — | 0.00 | −$1M | $0 | −$1M | — | — |
| FY2021 · to Jun 30 | — | — | −$34K | −$52K | — | -0.01 | $839K | $9K | $829K | — | — |
| FY2020 · to Jun 30 | $9.4M | 44.7% | −$1.4M | −$650K | -6.9% | -0.09 | −$168K | $60K | −$228K | — | — |
Every number comes from ESCALON MEDICAL CORP's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.